| STK11/LKB1 Mutations and PD-1 Inhibitor Resistance in KRAS-Mutant Lung Adenocarcinoma F Skoulidis, ME Goldberg, DM Greenawalt, MD Hellmann, MM Awad, ... Cancer discovery 8 (7), 822-835, 2018 | 1244 | 2018 |
| Association of patient characteristics and tumor genomics with clinical outcomes among patients with non–small cell lung cancer using a clinicogenomic database G Singal, PG Miller, V Agarwala, G Li, G Kaushik, D Backenroth, A Gossai, ... Jama 321 (14), 1391-1399, 2019 | 421 | 2019 |
| Lateralization of face processing in the human brain M Meng, T Cherian, G Singal, P Sinha Proceedings of the Royal Society B: Biological Sciences 279 (1735), 2052-2061, 2012 | 189 | 2012 |
| Somatic HLA class I loss is a widespread mechanism of immune evasion which refines the use of tumor mutational burden as a biomarker of checkpoint inhibitor response M Montesion, K Murugesan, DX Jin, R Sharaf, N Sanchez, A Guria, ... Cancer Discovery 11 (2), 282-292, 2021 | 154 | 2021 |
| Oncogene-specific differences in tumor mutational burden, PD-L1 expression, and outcomes from immunotherapy in non-small cell lung cancer MV Negrao, F Skoulidis, M Montesion, K Schulze, I Bara, V Shen, H Xu, ... Journal for immunotherapy of cancer 9 (8), 2021 | 135 | 2021 |
| Prevalence of high tumor mutational burden and association with survival in patients with less common solid tumors C Shao, G Li, L Huang, S Pruitt, E Castellanos, G Frampton, KR Carson, ... JAMA Network Open 3 (10), e2025109-e2025109, 2020 | 112 | 2020 |
| Real-world evidence in support of precision medicine: clinico-genomic cancer data as a case study V Agarwala, S Khozin, G Singal, C O’Connell, D Kuk, G Li, A Gossai, ... Health affairs 37 (5), 765-772, 2018 | 99 | 2018 |
| Predicting non-adherence with outpatient colonoscopy using a novel electronic tool that measures prior non-adherence DM Blumenthal, G Singal, SS Mangla, EA Macklin, DC Chung Journal of general internal medicine 30, 724-731, 2015 | 41 | 2015 |
| Mutational landscapes of smoking-related cancers in Caucasians and African Americans: precision oncology perspectives at Wake Forest Baptist Comprehensive Cancer Center V Kytola, U Topaloglu, LD Miller, RL Bitting, MM Goodman, ... Theranostics 7 (11), 2914, 2017 | 37 | 2017 |
| Enhancing the prediction of 30-day readmission after percutaneous coronary intervention using data extracted by querying of the electronic health record JH Wasfy, G Singal, C O’Brien, DM Blumenthal, KF Kennedy, JB Strom, ... Circulation: Cardiovascular Quality and Outcomes 8 (5), 477-485, 2015 | 30 | 2015 |
| Pre-capillary pulmonary hypertension and right ventricular dilation predict clinical outcome in cardiac resynchronization therapy NA Chatterjee, GA Upadhyay, G Singal, KA Parks, GW Dec, JP Singh, ... JACC: Heart Failure 2 (3), 230-237, 2014 | 30 | 2014 |
| Somatic HLA class I loss is a widespread mechanism of immune evasion which refines the use of tumor mutational burden as a biomarker of checkpoint inhibitor response. Cancer … M Montesion, K Murugesan, DX Jin, R Sharaf, N Sanchez, A Guria, ... CD-20-0672.[Abstract][CrossRef][Google Scholar], 0 | 30 | |
| STK11/LKB1 mutations and PD-1 inhibitor resistance in KRAS-mutant lung adenocarcinoma. Cancer Discov. 2018; 8 (7): 822–835. doi: 10.1158/2159-8290 F Skoulidis, ME Goldberg, DM Greenawalt, MD Hellmann, MM Awad, ... CD-18-0099, 0 | 27 | |
| Retrospective analysis of real-world data to determine clinical outcomes of patients with advanced non-small cell lung cancer following cell-free circulating tumor DNA genomic … R Madison, AB Schrock, E Castellanos, JP Gregg, J Snider, SM Ali, ... Lung Cancer 148, 69-78, 2020 | 26 | 2020 |
| STK11/LKB1 mutations and PD-1 inhibitor resistance in KRAS-mutant lung adenocarcinoma. Cancer Discov. 2018; 8 (7): 822–35 F Skoulidis, ME Goldberg, DM Greenawalt, MD Hellmann, MM Awad, ... External Resources Crossref (DOI), 0 | 22 | |
| Renal response in patients with chronic kidney disease predicts outcome following cardiac resynchronization therapy G Singal, GA Upadhyay, R Borgquist, DJ Friedman, NA Chatterjee, ... Pacing and Clinical Electrophysiology 38 (10), 1192-1200, 2015 | 18 | 2015 |
| Alpha-Cobb G, Guria A, He J, Frank S, Nunnally AC, Bailey M, Jaskiw A, Feuchtbaum D, Nussbaum N, Abernethy AP, Miller VA. Association of patient characteristics and tumor … G Singal Jama 321 (14), 1391-1399, 2019 | 17 | 2019 |
| STK11/LKB1 mutations and PD-1 inhibitor resistance in KRAS-mutant lung adenocarcinoma. Cancer Discov 8: 822–835 F Skoulidis, ME Goldberg, DM Greenawalt, MD Hellmann, MM Awad, ... | 16 | 2018 |
| Usefulness and consequences of cardiac resynchronization therapy in dialysis-dependent patients with heart failure DJ Friedman, GA Upadhyay, G Singal, M Orencole, SA Moore, KA Parks, ... The American journal of cardiology 112 (10), 1625-1631, 2013 | 16 | 2013 |
| Development and validation of a real-world clinicogenomic database. G Singal, PG Miller, V Agarwala, J He, A Gossai, S Frank, D Bourque, ... Journal of Clinical Oncology 35 (15_suppl), 2514-2514, 2017 | 14 | 2017 |
